Binflux is a cutting-edge software company with a powerful slogan - "Your trusted fertility software solution." The company, established in 2017, is focused on revolutionizing the clinical workflow of IVF centers. Its flagship product, Infans EMR, is a comprehensive and highly integrated data management and analytics system tailored for fertility specialty. The software encompasses cycle management, lab management, and statistics, strategically designed to align with the workplace strategy of IVF centers.
One of the remarkable features of Binflux's offering is the Infans CareU App, which enables the seamless sharing of treatment data and medical images with patients, thereby fostering stronger trust in the medical relationship. The company operates at the intersection of AI, Internet, and Marketing industries, positioning itself at the forefront of technological innovation in the healthcare sector.
As of now, specific details regarding the headquarter and recent investments are not disclosed. However, with its commitment to leveraging technology to enhance fertility treatments and clinical operations, Binflux presents a promising opportunity for potential venture capital investors seeking to tap into the burgeoning market of healthcare tech solutions.
There is no investment information
No recent news or press coverage available for Binflux.